What is the recommended dosage and administration schedule of chlorpromazine for treating intractable hiccups?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chlorpromazine Dosage for Intractable Hiccups

For intractable hiccups, start with chlorpromazine 25-50 mg orally three to four times daily (t.i.d. or q.i.d.), and if symptoms persist for 2-3 days, switch to parenteral therapy. 1

Dosing Algorithm

Initial Oral Therapy

  • Start with 25-50 mg orally three to four times daily (every 6-8 hours)
  • Continue this regimen for 2-3 days to assess response
  • This is the FDA-approved dosing specifically for intractable hiccups 1

If Oral Therapy Fails

  • Switch to parenteral (intramuscular) chlorpromazine after 2-3 days of persistent symptoms 1
  • The FDA label explicitly states that "if symptoms persist for 2 to 3 days, parenteral therapy is indicated" 1

Evidence Supporting Lower Doses

Recent systematic review data suggests that complete resolution of hiccups can occur with doses as low as 10-25 mg (oral or intramuscular) 2. This is particularly relevant when balancing efficacy against side effects in vulnerable patients.

Critical Safety Considerations

Immediate Monitoring Requirements

  • Check complete blood count (CBC) before starting therapy and monitor frequently during the first few months, as chlorpromazine can cause leukopenia, neutropenia, and agranulocytosis 1
  • One case report documented fatal agranulocytosis within less than one week of starting 25 mg three times daily 3, highlighting the rapid onset potential of this life-threatening complication

Patient-Specific Precautions

  • Use only in bed-bound patients if giving intravenously due to severe hypotensive effects 4
  • Reduce dosage in elderly, debilitated, or emaciated patients - they are more susceptible to hypotension and neuromuscular reactions 1
  • Avoid in patients with cardiovascular, liver, or renal disease unless benefits clearly outweigh risks 1

When to Stop Immediately

  • Discontinue at first sign of WBC decline without other causative factors 1
  • Stop if fever or signs of infection develop, especially with neutropenia 1
  • Monitor for severe neutropenia (absolute neutrophil count <1000/mm³) which mandates immediate discontinuation 1

Duration of Therapy

  • Chlorpromazine can usually be discontinued after several weeks for intractable hiccups 1
  • However, some patients may require maintenance therapy 1
  • The goal is to use the lowest effective maintenance dose after symptoms are controlled 1

Alternative Considerations

While chlorpromazine remains the FDA-approved first-line agent for intractable hiccups, recent evidence suggests olanzapine (2.5-10 mg orally) also demonstrates complete resolution with potentially fewer side effects 2. However, chlorpromazine has the strongest regulatory approval and longest track record for this specific indication.

References

Research

A Medication Hiccup: Chlorpromazine-Induced Agranulocytosis in a 72-Year-Old Male.

WMJ : official publication of the State Medical Society of Wisconsin, 2022

Guideline

palliative care version 1.2016.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.